[Federal Register Volume 82, Number 187 (Thursday, September 28, 2017)]
[Notices]
[Pages 45298-45299]
[FR Doc No: 2017-20778]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-0001]

Request for Nominations on Public Advisory Panels of the Medical
Devices Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that any
industry organizations interested in participating in the selection of
nonvoting industry representatives to serve on certain panels of the
Medical Devices Advisory Committee (MDAC or Committee) in the Center
for Devices and Radiological Health (CDRH) notify FDA in writing. FDA
is also requesting nominations for nonvoting industry representatives
to serve on certain device panels of the MDAC in the CDRH. A nominee
may either be self-nominated or nominated by an organization to serve
as a nonvoting industry representative. Nominations will be accepted
for current and upcoming vacancies effective with this notice.

DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests must send a letter stating that interest to the FDA by
October 30, 2017 (see sections I and II of this document for further
details). Concurrently, nomination materials for prospective candidates
should be sent to FDA by October 30, 2017.

ADDRESSES: All statements of interest from industry organizations
interested in participating in the selection process of nonvoting
industry representative nomination should be sent to Margaret Ames (see
FOR FURTHER INFORMATION CONTACT). All nominations for nonvoting
industry representatives should be submitted electronically by
accessing the FDA Advisory Committee Membership Nomination Portal:
https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or
by mail to Advisory Committee Oversight and Management Staff, Food and
Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103,
Silver Spring, MD 20993-0002. Information about becoming a member of an
FDA advisory committee can also be obtained by visiting FDA's Web site
at https://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Margaret Ames, Division of Workforce
Management, Center for Devices and Radiological Health, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5264, Silver
Spring, MD 20993,<PHONE_NUMBER>, Fax:<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The Agency is requesting nominations for
nonvoting industry representatives to the panels listed in the table in
this document.

I. Medical Devices Advisory Committee

    The Committee reviews and evaluates data on the safety and
effectiveness of marketed and investigational devices and makes
recommendations for their regulation. The panels engage in a number of
activities to fulfill the functions the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) envisions for device advisory panels. With
the exception of the Medical Devices Dispute Resolution Panel, each
panel, according to its specialty area, advises the Commissioner of
Food and Drugs (the Commissioner) regarding recommended classification
or reclassification of devices into one of three regulatory categories;
advises on any possible risks to health associated with the use of
devices; advises on formulation of product development protocols;
reviews premarket approval applications for medical devices; reviews
guidelines and guidance documents; recommends exemption of certain
devices from the application of portions of the FD&C Act; advises on
the necessity to ban a device; and responds to requests from the agency
to review and make recommendations on specific issues or problems
concerning the safety and effectiveness of devices. With the exception
of the Medical Devices Dispute Resolution Panel, each panel, according
to its specialty area, may also make appropriate recommendations to the
Commissioner on issues relating to the design of clinical studies
regarding the safety and effectiveness of marketed and investigational
devices. The Committee also provides recommendations to the
Commissioner or designee on complexity categorization of in vitro
diagnostics under the Clinical Laboratory Improvement Amendments of
1988.

------------------------------------------------------------------------
              Panels                              Function
------------------------------------------------------------------------
Circulatory System Devices Panel..  Reviews and evaluates data
                                     concerning the safety and
                                     effectiveness of marketed and
                                     investigational devices for use in
                                     the circulatory and vascular
                                     systems and makes appropriate
                                     recommendations to the Commissioner
                                     of Food and Drugs.
Clinical Chemistry and Clinical     Reviews and evaluates data
 Toxicology Devices Panel.           concerning the safety and
                                     effectiveness of marketed and
                                     investigational in vitro devices
                                     for use in clinical laboratory
                                     medicine including clinical
                                     toxicology, clinical chemistry,
                                     endocrinology, and oncology and
                                     makes appropriate recommendations
                                     to the Commissioner of Food and
                                     Drugs.
Gastroenterology and Urology        Reviews and evaluates data
 Devices Panel.                      concerning the safety and
                                     effectiveness of marketed and
                                     investigational gastroenterology,
                                     urology, and nephrology devices and
                                     makes appropriate recommendations
                                     to the Commissioner of Food and
                                     Drugs.
General Hospital and Personal Use   Reviews and evaluates data
 Devices Panel.                      concerning the safety and
                                     effectiveness of marketed and
                                     investigational general hospital,
                                     infection control, and personal use
                                     devices and makes appropriate
                                     recommendations to the Commissioner
                                     of Food and Drugs.
Obstetrics and Gynecology Devices   Reviews and evaluates data
 Panel.                              concerning the safety and
                                     effectiveness of marketed and
                                     investigational devices for use in
                                     obstetrics and gynecology and makes
                                     appropriate recommendations to the
                                     Commissioner of Food and Drugs.

Ophthalmic Devices Panel..........  Reviews and evaluates data
                                     concerning the safety and
                                     effectiveness of marketed and
                                     investigational devices for use in
                                     the eye and makes appropriate
                                     recommendations to the Commissioner
                                     of Food and Drugs.
------------------------------------------------------------------------

II. Qualifications

    Persons nominated for the device panels should be full-time
employees of firms that manufacture products that would come before the
panel, or consulting firms that represent manufacturers, or have
similar appropriate ties to industry.

III. Selection Procedure

    Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests should send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of
this document (see DATES). Within the subsequent 30 days, FDA will send
a letter to each organization that has expressed an interest, attaching
a complete list of all such organizations; and a list of all nominees
along with their current resumes. The letter will also state that it is
the responsibility of the interested organizations to confer with one
another and to select a candidate, within 60 days after the receipt of
the FDA letter, to serve as the nonvoting member to represent industry
interests for a particular device panel. The interested organizations
are not bound by the list of nominees in selecting a candidate.
However, if no individual is selected within 60 days, the Commissioner
will select the nonvoting member to represent industry interests.

IV. Application Procedure

    Individuals may self-nominate and/or an organization may nominate
one or more individuals to serve as a nonvoting industry
representative. Contact information, a current curriculum vitae, and
the name of the panel of interest should be sent to the FDA Advisory
Committee Membership Nomination Portal (see ADDRESSES) within 30 days
of publication of this document (see DATES). FDA will forward all
nominations to the organizations expressing interest in participating
in the selection process for the particular device panels listed in the
table. (Persons who nominate themselves as nonvoting industry
representatives will not participate in the selection process).
    FDA seeks to include the views of women and men, members of all
racial and ethnic groups, and individuals with and without disabilities
on its advisory committees and, therefore encourages nominations of
appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: September 22, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-20778 Filed 9-27-17; 8:45 am]
 BILLING CODE 4164-01-P


Dear sirs, i feel that Non-Profit 501C3 organizations operating under an approved exemption letter, such as Exemption 6540f, should be totally exempted from the proposed National Ait Tour Safety Standards.

As long as these aircraft pass air worthiness tests, and are properly manned, the experience of riding these aircraft should be open to us.

This is history that we are entitled to experience.


[Federal Register Volume 82, Number 172 (Thursday, September 7, 2017)]
[Notices]
[Pages 42374-42375]
[FR Doc No: 2017-18929]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Investment Company Act Release No. 32803; 812-14797]

Northern Lights Fund Trust IV and Measured Risk Portfolios, Inc.

August 31, 2017.
AGENCY: Securities and Exchange Commission.

ACTION:  Notice.

-----------------------------------------------------------------------

    Notice of an application under section 6(c) of the Investment
Company Act of 1940 (``Act'') for an exemption from section 15(a) of
the Act and rule 18f-2 under the Act, as well as from certain
disclosure requirements in rule 20a-1 under the Act, Item 19(a)(3) of
Form N-1A, Items 22(c)(1)(ii), 22(c)(1)(iii), 22(c)(8) and 22(c)(9) of
Schedule 14A under the Securities Exchange Act of 1934, and sections 6-
07(2)(a), (b), and (c) of Regulation S-X (``Disclosure Requirements'').
The requested exemption would permit an investment adviser to hire and
replace certain subadvisers without shareholder approval and grant
relief from the Disclosure Requirements as they relate to fees paid to
the subadvisers.

Applicants: Northern Lights Fund Trust IV (the ``Trust''), a Delaware
statutory trust registered under the Act as an open-end management
investment company, and Measured Risk Portfolios, Inc. (the ``Initial
Adviser''), a California corporation registered as an investment
adviser under the Investment Advisers Act of 1940 (collectively with
the Trust, the ``Applicants'').

Filing Dates: The application was filed on July 7, 2017 and amended on
August 14, 2017 and August 25, 2017.

Hearing or Notification of Hearing: An order granting the application
will be issued unless the Commission orders a hearing. Interested
persons may request a hearing by writing to the Commission's Secretary
and serving applicants with a copy of the request, personally or by
mail. Hearing requests should be received by the Commission by 5:30
p.m. on September 25, 2017, and should be accompanied by proof of
service on the applicants, in the form of an affidavit or, for lawyers,
a certificate of service. Pursuant to rule 0-5 under the Act, hearing
requests should state the nature of the writer's interest, any facts
bearing upon the desirability of a hearing on the matter, the reason
for the request, and the issues contested. Persons who wish to be
notified of a hearing may request notification by writing to the
Commission's Secretary.

ADDRESSES: Secretary, U.S. Securities and Exchange Commission, 100 F
Street NE., Washington, DC 20549-1090. Applicants: Jennifer Farrell,
Secretary, Northern Lights Fund Trust IV, 80 Arkay Drive, Suite 110,
Hauppauge, NY 11788.

FOR FURTHER INFORMATION CONTACT:  Courtney S. Thornton, Senior Counsel,
at<PHONE_NUMBER>, or Robert H. Shapiro, Branch Chief, at (202) 551-
6821 (Division of Investment Management, Chief Counsel's Office).

SUPPLEMENTARY INFORMATION:  The following is a summary of the
application. The complete application may be obtained via the
Commission's Web site by searching for the file number, or an applicant
using the Company name box, at http://www.sec.gov/search/search.htm or
by calling<PHONE_NUMBER>.

Summary of the Application

    1. The Adviser will serve as the investment adviser to the Funds
pursuant to an investment advisory agreement with the Trust (the
``Advisory Agreement'').\1\ The Adviser will provide each Fund with
overall investment management services and will continuously review,
supervise and administer each Fund's investment program, subject to the
supervision of, and policies established by, each Fund's board of
trustees (``Board''). The Advisory Agreement permits the Adviser,
subject to the approval of the Board, to delegate to one or more
subadvisers (each, a ``Subadviser'' and collectively, the
``Subadvisers'') the responsibility to provide the day-to-day portfolio
investment management of each Fund, subject to the supervision and
direction of the Adviser.\2\ The primary responsibility for managing
the Funds will remain vested in the Adviser. The Adviser will hire,
evaluate, allocate assets to and oversee the Subadvisers, including
determining whether a Subadviser should be terminated, at all times
subject to the authority of the Board.
---------------------------------------------------------------------------

    \1\ Applicants request relief with respect to any existing or
future series of the Trust or any other registered open-end
management company that: (a) Is advised by the Initial Adviser, or
any person controlling, controlled by or under common control with
the Initial Adviser or its successors (each, an ``Adviser''); (b)
uses the manager of managers structure described in the application;
and (c) complies with the terms and conditions of the application
(any such series, a ``Fund'' and collectively, the ``Funds''). For
purposes of the requested order, ``successor'' is limited to an
entity that results from a reorganization into another jurisdiction
or a change in the type of business organization.
    \2\ The Initial Adviser already has hired a subadviser for the
Measured Risk Strategy Fund in compliance with section 15(a) of the
Act.
---------------------------------------------------------------------------

    2. Applicants request an exemption to permit the Adviser, subject
to Board approval, to hire certain Subadvisers pursuant to subadvisory
agreements and materially amend existing subadvisory agreements without
obtaining the shareholder approval required under section 15(a) of the
Act and rule 18f-2 under the Act.\3\ Applicants also seek an exemption
from the Disclosure Requirements to permit a Fund to disclose (as both
a dollar amount and a percentage of the Fund's net assets): (a) The
aggregate fees paid to the Adviser and any Affiliated Subadviser; and
(b) the aggregate fees paid to Subadvisers other than Affiliated
Subadvisers. For any Fund that employs an Affiliated Subadviser, the
Fund will provide separate disclosure of any fees paid to the
Affiliated Subadviser.
---------------------------------------------------------------------------

    \3\ The requested relief will not extend to any subadviser that
is an affiliated person, as defined in section 2(a)(3) of the Act,
of the Trust, a Fund, or the Adviser, other than solely by reason of
serving as a Subadviser to one or more of the Funds, or as an
adviser or subadviser to any series of the Trust other than the
Funds (``Affiliated Subadviser'').
---------------------------------------------------------------------------

    3. Applicants agree that any order granting the requested relief
will be subject to the terms and conditions stated in the application.
Such terms and conditions provide for, among other safeguards,
appropriate disclosure to Fund shareholders and notification about
subadvisory changes and enhanced Board oversight to protect the
interests of the Funds' shareholders.
    4. Section 6(c) of the Act provides that the Commission may exempt
any person, security, or transaction or any class or classes of
persons, securities, or transactions from any provisions of the Act, or
any rule thereunder, if such relief is necessary or appropriate in the
public interest and consistent with the protection of investors and
purposes fairly intended by the policy and provisions of the Act.
Applicants believe that the requested relief meets this standard
because, as further explained in the application, the Advisory
Agreements will remain subject to shareholder approval while the role
of the Subadvisers is substantially similar to that of individual
portfolio managers, so that requiring shareholder approval of
subadvisory agreements would impose unnecessary delays and expenses on
the Funds. Applicants believe that the requested relief from the
Disclosure Requirements meets this standard because it will improve the
Adviser's ability to negotiate fees paid to the Subadvisers that are
more advantageous for the Funds.

    For the Commission, by the Division of Investment Management,
under delegated authority.
Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2017-18929 Filed 9-6-17; 8:45 am]
 BILLING CODE P


[Federal Register: November 2, 2007 (Volume 72, Number 212)]
[Notices]
[Page 62237-62238]
[DOCID:fr02no07-47]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2007-1015; FRL-8153-8]

Notice of Filing of Pesticide Petitions for Residues of Pesticide
Chemicals in or on Various Commodities

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the initial filing of pesticide
petitions proposing the establishment or modification of regulations
for residues of pesticide chemicals in or on various commodities.

DATES: Comments must be received on or before December 3, 2007.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2007-1015 and the pesticide petition number (PP)
of interest, by one of the following methods:
     Federal eRulemaking Portal:  http://www.regulations.gov.

Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket's normal hours of operation (8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays). Special
arrangements should be made for deliveries of boxed information. The
Docket Facility telephone number is<PHONE_NUMBER>.
    Instructions: Direct your comments to EPA-HQ-OPP-2007-1015 and the
pesticide petition number of interest. EPA's policy is that all
comments received will be included in the docket without change and may
be made available on-line at http://www.regulations.gov, including any

personal information provided, unless the comment includes information
claimed to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. Do not submit
information that you consider to be CBI or otherwise protected through
regulations.gov or e-mail. The regulations.gov website is an
``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the docket and made available on the Internet. If you submit
an electronic comment, EPA recommends that you include your name and
other contact information in the body of your comment and with any disk
or CD-ROM you submit. If EPA cannot read your comment due to technical
difficulties and cannot contact you for clarification, EPA may not be
able to consider your comment. Electronic files should avoid the use of
special characters, any form of encryption, and be free of any defects
or viruses.
    Docket: All documents in the docket are listed in the docket index
available in regulations.gov. To access the electronic docket, go to
http://www.regulations.gov, select ``Advanced Search,'' then ``Docket

Search.'' Insert the docket ID number where indicated and select the
``Submit'' button. Follow the instructions on the regulations.gov
website to view the docket index or access available documents.
Although listed in the index, some information is not publicly
available, e.g., CBI or other information whose disclosure is
restricted by statute. Certain other material, such as copyrighted
material, is not placed on the Internet and will be publicly available
only in hard copy. Publicly available docket materials are available
electronically at http://www.regulations.gov, or, if only available in

hard copy, at the OPP Regulatory Public Docket in Rm. S-4400, One
Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The
hours of operation of this Docket Facility are from 8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays. The Docket
Facility telephone number is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: The person listed at the end of the
pesticide petition summary of interest.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).
    This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed at the end of the pesticide petition
summary of interest.

B. What Should I Consider as I Prepare My Comments for EPA?

     1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or e-mail. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
     2. Tips for preparing your comments. When submitting comments,
remember to:
    i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a

Code of Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    iv. Describe any assumptions and provide any technical information
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    viii. Make sure to submit your comments by the comment period
deadline identified.

II. Docket ID Numbers

    When submitting comments, please use the docket ID number and the
pesticide petition number of interest, as shown in the table.

------------------------------------------------------------------------
                 PP Number                        Docket ID Number
------------------------------------------------------------------------
PP 7F7236                                   EPA-HQ-OPP-2007-1020
------------------------------------------------------------------------
PP 7F7254                                   EPA-HQ-OPP-2007-0830
------------------------------------------------------------------------
PP 7F7249                                   EPA-HQ-OPP-2007-1025
------------------------------------------------------------------------

III. What Action is the Agency Taking?

    EPA is printing notice of the filing of pesticide petitions
received under section 408 of the Federal Food, Drug, and Cosmetic Act
(FFDCA), 21 U.S.C. 346a, proposing the establishment or modification of
regulations in 40 CFR part 180 for residues of pesticide chemicals in
or on various food commodities. EPA has determined that the pesticide
petitions described in this notice contain data or information
regarding the elements set forth in FFDCA section 408(d)(2); however,
EPA has not fully evaluated the sufficiency of the submitted data at
this time or whether the data support granting of the pesticide
petitions. Additional data may be needed before EPA rules on these
pesticide petitions.
    Pursuant to 40 CFR 180.7(f), a summary of each of the petitions
included in this notice, prepared by the petitioner, is included in a
docket EPA has created for each rulemaking. The docket for each of the
petitions is available on-line at http://www.regulations.gov.

A. Amendment to Existing Tolerance Exemption

    1. PP 7F7236. Growth Products Ltd., P.O. Box 1259, White Plains, NY
10602, proposes to amend the tolerance exemption in 40 CFR 180.1111 for
residues of the fungicide Bacillus subtilis GB03 tolerance in or on all
raw agricultural commodities when applied as a seed treatment for
growing agricultural crops in accordance with good agricultural
practice. Because this petition is a request for an exemption from the
requirement of a tolerance without numerical limitations, no analytical
method is required. Contact: Susanne Cerrelli,<PHONE_NUMBER>,
<EMAIL_ADDRESS>

B. New Exemptions from Tolerance

    2. PP 7F7254. Syngenta Seeds, Inc., P.O. Box 12257, 3054 E.
Cornwallis Rd., Research Triangle Park, NC 27709, proposes to establish
an exemption from the requirement of a tolerance for residues of the
plant-incorporated protectant, Bacillus thuringiensis Vip3Aa proteins
in all plants when used as plant-incorporated protectants in all crops
and agricultural commodities. Syngenta's original petition requested an
exemption for Bacillus thuringiensis Vip3Aa19 and Vip3Aa20 proteins in
all plants; however, this original request was amended by Syngenta in a
letter to the Agency dated September 6, 2007 to Bacillus thuringiensis
Vip3Aa proteins in all plants. The petition includes a reference to a
description of the analytical methods available to EPA for the
detection and measurement of the pesticide chemical residues or an
explanation of why no such method is needed. Contact: Alan Reynolds,
(703) 605-0515<EMAIL_ADDRESS>    3. PP 7F7249. Plasma Power Limited of India, c/o OMC Ag Consulting,
828 Tanglewood Lane, East Lancing, MI 48823, proposes to establish an
exemption from the requirement of a tolerance for residues of the
insecticide, Plasma Neem Oil\TM\ Manufacturing Use Product in or on all
food commodities. Because this petition is a request for an exemption
from the requirement of a tolerance without numerical limitations, no
analytical method is required. Contact: Driss Benmhend,<PHONE_NUMBER>,
<EMAIL_ADDRESS>

List of Subjects

    Environmental protection, Agricultural commodities, Feed additives,
Food additives, Pesticides and pests, Reporting and recordkeeping
requirements.

    Dated: October 24, 2007.
Janet L. Andersen,
Director, Biopesticides and Pollution Prevention Division, Office of
Pesticide Programs.
[FR Doc. E7-21601 Filed 11-1-07; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register: December 19, 2006 (Volume 71, Number 243)]
[Notices]
[Page 75961]
[DOCID:fr19de06-57]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings  1

December 12, 2006.
    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC06-165-000.
    Applicants: Pinnacle West Capital Corporation; Pinnacle West
Marketing & Trading.
    Description: Pinnacle West Capital Corp and Pinnacle West Marketing
& Trading Co, LLC submits a response to inquiry on its proposed
accounting entries pursuant to the Commission's 11/6/06 letter order.
    Filed Date: 12/06/2006.
    Accession Number: 20061212-0075.
    Comment Date: 5 p.m. Eastern Time on Wednesday, December 27, 2006.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER04-691-079.
    Applicants: Midwest ISO.
    Description: Midwest Independent Transmission System Operator, Inc.
submits its Errata to the Compliance Filing made on 11/27/06.
    Filed Date: 12/08/2006.
    Accession Number: 20061212-0063.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER06-1177-002.
    Applicants: PJM Interconnection, L.L.C.
    Description: PJM Interconnection LLC submits revisions to its OATT
pursuant to the Commission's 11/9/06 order.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0069.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER06-1549-001.
    Applicants: Duquesne Power and Light Company.
    Description: Duquesne Light Company submits responses to the
Commission Staff's questions in the 11/30/06 letter.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0058.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER07-52-001.
    Applicants: MidAmerican Energy Company.
    Description: MidAmerican Energy submits a revised Attachment 1
which consist of the clean version of the Amended and Restated Electric
Interconnection Agreement.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0070.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER07-307-000.
    Applicants: Kentucky Utilities Company.
    Description: Kentucky Utilities Company submits an amendment to a
contract with the City of Nicholasville, Kentucky, Rate Schedule 307.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0063.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER07-308-000.
    Applicants: Kentucky Utilities Company.
    Description: Kentucky Utilities Company submits an amendment to a
contract with Frankfort Electric and Water Board of Frankfort, KY aka
City of Frankfort, FERC Rate Schedule 311.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0062.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER07-309-000.
    Applicants: The Clark Fork and Blackfoot, L.L.C.
    Description: The Clark Fork and Blackfoot, LLC submits a notice of
cancellation of its market-based rate tariff, FERC Electric Tariff,
First Revised Volume 1.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0061.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER07-310-000.
    Applicants: Carolina Power & Light Company.
    Description: Carolina Power & Light Co. submits a Notice of
Cancellation of Rate Schedule 138, Netting Agreement with AYP Energy,
Inc.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0060.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Docket Numbers: ER07-311-000.
    Applicants: Kentucky Utilities Company
    Description: Kentucky Utilities Co submits an amendment to a
contract with the City of Bardstown, Kentucky, Rate Schedule 302.
    Filed Date: 12/08/2006.
    Accession Number: 20061211-0059.
    Comment Date: 5 p.m. Eastern Time on Friday, December 29, 2006.

    Any person desiring to intervene or to protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Rules of Practice and Procedure (18 CFR 385.211 and
385.214) on or before 5 p.m. Eastern time on the specified comment
date. It is not necessary to separately intervene again in a subdocket
related to a compliance filing if you have previously intervened in the
same docket. Protests will be considered by the Commission in
determining the appropriate action to be taken, but will not serve to
make protestants parties to the proceeding. Anyone filing a motion to
intervene or protest must serve a copy of that document on the
Applicant. In reference to filings initiating a new proceeding,
interventions or protests submitted on or before the comment deadline
need not be served on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov.
 To facilitate electronic service, persons with Internet

access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First St., NE., Washington, DC 20426.
    The filings in the above proceedings are accessible in the
Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive e-mail notification
when a document is added to a subscribed dockets(s). For assistance
with any FERC Online service, please e-mail<EMAIL_ADDRESS>
or call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-21606 Filed 12-18-06; 8:45 am]

BILLING CODE 6717-01-P